Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Imig

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Frontiers in Physiology|July 10, 2023
Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertensionJohn D Imig
Hypertension (Dallas, Tex. : 1979)|January 14, 2015
Epoxyeicosatrienoic acids, hypertension, and kidney injuryJohn D Imig
Pharmacology & Therapeutics|July 3, 2018
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeuticsJohn D Imig
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
Bioactive lipids in hypertensionJohn D Imig
Frontiers in Physiology|March 20, 2023
Editorial: The future of physiology: 2020 and beyond, Volume IIIJohn D Imig
Hypertension (Dallas, Tex. : 1979)|September 15, 2010
20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertensionJohn D Imig
Hypertension (Dallas, Tex. : 1979)|February 6, 2004
ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF InvolvementJohn D Imig
Clinical Science (London, England : 1979)|October 23, 2020
Eicosanoid blood vessel regulation in physiological and pathological statesJohn D Imig
Advances in Pharmacology (San Diego, Calif.)|June 6, 2022
Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injuryJohn D Imig
Kidney360|October 17, 2022
Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKDJohn D Imig
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Frontiers in Physiology|July 10, 2023
Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertensionJohn D Imig
Hypertension (Dallas, Tex. : 1979)|January 14, 2015
Epoxyeicosatrienoic acids, hypertension, and kidney injuryJohn D Imig
Pharmacology & Therapeutics|July 3, 2018
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeuticsJohn D Imig
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
Bioactive lipids in hypertensionJohn D Imig
Frontiers in Physiology|March 20, 2023
Editorial: The future of physiology: 2020 and beyond, Volume IIIJohn D Imig
Hypertension (Dallas, Tex. : 1979)|September 15, 2010
20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertensionJohn D Imig
Hypertension (Dallas, Tex. : 1979)|February 6, 2004
ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF InvolvementJohn D Imig
Clinical Science (London, England : 1979)|October 23, 2020
Eicosanoid blood vessel regulation in physiological and pathological statesJohn D Imig
Advances in Pharmacology (San Diego, Calif.)|June 6, 2022
Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injuryJohn D Imig
Kidney360|October 17, 2022
Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKDJohn D Imig
Pageof 20